Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce blood glucose, blood pressure, and body weight in patients with type 2 diabetes (T2D). However, the comparative long-term effectiveness and safety of SGLT2i among similar drugs, administered at different doses, have not been asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ai-Yu, Chen, Hung-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152409/
https://www.ncbi.nlm.nih.gov/pubmed/35656359
http://dx.doi.org/10.1155/2022/2420857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152409/
https://www.ncbi.nlm.nih.gov/pubmed/35656359
http://dx.doi.org/10.1155/2022/2420857

Ejemplares similares